5/14/2014 6:20:56 AM
KANSAS CITY, Kan., May 13, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion animals, today announced its first quarter 2014 financial results.
Help employers find you! Check out all the jobs and post your resume.
comments powered by